Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (378)
- Scheduling (national classification system) (176)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (8)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Fees and payments (5)
- Sunscreens (5)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
773 result(s) found, displaying 651 to 675
-
Meeting statementsThe meeting statement for the Therapeutic Goods Committee is now available
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 305 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 22 statement.
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 21 statement.
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 304 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 6 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 20 meeting statement.
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 302 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 303 statement
-
Corporate reportsWe developed a brochure to encourage health professionals to report adverse events or incidents related to the use of medical devices.
-
Corporate reportsEach year, approximately 40 new prescription medicines containing new active substances are registered.
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 19 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 18 meeting statement
-
Corporate reportsThe Scheduling Policy Framework (SPF) is a key feature of the revised arrangements for scheduling of medicines and chemicals
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 301 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 16 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 17 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the fifth time on 5 August 2014
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 300 statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 296 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 297 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 298 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 299 statement